Valuing methadone takeaway doses: The contribution of service-user perspectives to policy and practice

References

• Australian Injecting & Illicit Drug Users League. Policy position consumer representation. Australian Injecting & Illicit Drug Users League, CanberraAustralia 2004
   Google Scholar
• Bell J, Dru A, Fischer B, Levit S, Sarfraz M. Substitution therapy for heroin addiction. Substance Use and Misuse 2002; 37: 1149–1178
   PubMed Web of Science ®Google Scholar
• Boeri M. ‘Hell, I’m an addict, but I ain’t no junkie’: An ethnographic analysis of aging heroin users.’. Human Organization 2004; 63(2)236–245
   Web of Science ®Google Scholar
• Canadian HIV/AIDS Legal Network. ‘Nothing about us without us’, greater, meaningful involvement of people who use illegal drugs: A public health, ethical, and human rights imperative. Canadian HIV/AIDS Legal Network, TorontoCanada 2005
   Google Scholar
• Caplehorn JR, Lumley T, Irwig L, Saunders J. Changing attitudes and beliefs of staff working in methadone maintenance programs. Australian & New Zealand Journal of Public Health 1998; 22: 505–508
   PubMed Web of Science ®Google Scholar
• Crawford M, Rutter D, Manley C, Weaver T, Bhui K, Fulop N, et al. Systematic review of involving patients in the planning and development of healthcare. British Medical Journal 2002; 325: 1263–1267
   PubMed Web of Science ®Google Scholar
• Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug and Alcohol Review 2002; 21: 27–32
   PubMed Web of Science ®Google Scholar
• Drugs & Poisons Regulations Group. Policy for maintenance pharmacotherapy for opioid dependence. Department of Human Services, MelbourneAustralia 2006
   Google Scholar
• Fischer B, Chin A, Kup I, Kirst M, Vlahov D. Canadian illicit opiate users’ views on methadone and other opiate prescription treatment. Substance Use and Misuse 2002; 37: 495–522
   PubMed Web of Science ®Google Scholar
• Fraser S. The chronotope of the queue: Methadone maintenance treatment and the production of time, space and subjects. International Journal of Drug Policy 2006; 17: 192–202
   Web of Science ®Google Scholar
• Grbich C. Qualitative research in health: An introduction. Allen & Unwin, SydneyAustralia 1999
   Google Scholar
• Hamner K. Gay-bashing: A social identity analysis of violence against lesbians and gay men. Hate crimes: Confronting violence against lesbians and gay men, G Herek, K Berrill. Sage, Newbury Park, CA 1992
   Google Scholar
• Hopwood M, Southgate E, Kippax S, Bammer G, Isaac-Toua G, MacDonald M. The injection of methadone syrup in New South Wales: Patterns of use and increased harm after partial banning of injecting equipment. Australian and New Zealand Journal of Public Health 2003; 27: 551–555
   PubMed Web of Science ®Google Scholar
• Jones S, Power R, Dale A. The patients’ charter: Drug users’ views on the ‘ideal’ methadone programme. Addiction Research 1994; 1: 323–334
   Google Scholar
• Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: A tale of two cities. Addiction 1999; 94: 1175–1178
   PubMed Web of Science ®Google Scholar
• Magura S, Nwakeze PC, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93: 51–60
   PubMed Web of Science ®Google Scholar
• Magura S, Nwakeze PC, Kang S-Y, Demsky S. Program quality effects on patient outcomes during methadone maintenance: A study of 17 clinics. Substance Use and Misuse 1999; 34: 1299–1324
   PubMed Web of Science ®Google Scholar
• Montagne M. Appreciating the user's perspective: Listening to the ‘Methadonians’. Substance Use and Misuse 2002; 37: 565–570
   PubMed Web of Science ®Google Scholar
• National Treatment Agency for Substance Misuse. Corporate strategy 2002—2005: More treatment, better treatment, fairer treatment. National Treatment Agency for Substance Misuse, London 2001
   Google Scholar
• National Treatment Agency for Substance Misuse. Making a difference to drug treatment services: Notable examples of user and carer involvement. National Treatment Agency for Substance Misuse, London 2004
   Google Scholar
• National Treatment Agency for Substance Misuse. User and carer involvement: Guidance notes to adult drug treatment plan 2006/07. National Treatment Agency for Substance Misuse, London 2005
   Google Scholar
• Neale J. Drug users’ views of prescribed methadone. Drugs: Education, Prevention & Policy 1998; 5: 33–45
   Web of Science ®Google Scholar
• Neale J. Drug users’ views of substitute prescribing conditions. International Journal of Drug Policy 1999a; 10: 247–258
   Google Scholar
• Neale J. Understanding drug-using clients’ views of substitute prescribing. British Journal of Social Work 1999b; 29: 127–145
   Web of Science ®Google Scholar
• NSW Health Department. NSW methadone maintenance treatment clinical practice guidelines. NSW Health Department, SydneyAustralia 1999
   Google Scholar
• Pani P, Pirastu R. Take-home and compliance with methadone maintenance treatment. Heroin Addiction and Related Clinical Problems 2000; 2: 33–38
   Google Scholar
• Psychogios C, Bareja M. Alcohol and other drug treatment services in Australia 2003–04 (Drug Treatment Series Number 4). Australian Institute of Health and Welfare, CanberraAustralia 2005
   Google Scholar
• Tajfel H. Human groups and social categories. Cambridge University Press, Cambridge, UK 1981
   Google Scholar
• Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment, M Teesson, H Proudfoot. Australian Government Department of Health and Ageing, CanberraAustralia 2003
   Google Scholar
• Treloar C, Abelson J, Cao W, Brener L, Kippax S, Schultz L, et al. Barriers and incentives to treatment for illicit drug users. Commonwealth Department of Health and Ageing, CanberraAustralia 2004
   Google Scholar
• Tritter J, McCallum A. The snakes and ladders of user involvement: Moving beyond Arnstein. Health Policy 2006; 79: 156–168
   Web of Science ®Google Scholar
• Victorian Government Department of Human Services. Consultation paper: Participation in your health service system; Victorian consumers, carers, and the community working together with their health service and the Department of Human Services. Victorian Government Department of Human Services, MelbourneAustralia 2005
   Google Scholar
• Vormfelde S, Poser W. Death attributed to methadone. Pharmacopsychiatry 2001; 34: 217–222
   PubMed Web of Science ®Google Scholar
• Wilkinson R. Putting the picture together: Prosperity, redistribution, health and welfare. Social determinants of health, M Marmot, R Wilkinson. Oxford University Press, Oxford, UK 1999
   Google Scholar
• Willke R, Burke L, Erickson P. Measuring treatment impact: A review of patient-reported outcomes and other efficacy endpoints in approved product labels. Controlled Clinical Trials 2004; 25: 535–552
   PubMedGoogle Scholar
• Wodak A. All drug politics is local. International Journal of Drug Policy 2006; 17: 83–84
   Web of Science ®Google Scholar
• Wodak A, Lynch P, Crofts N. Is lawful discrimination against illicit drug users acceptable?. Medical Journal of Australia 2004; 180: 405–407
   PubMed Web of Science ®Google Scholar
• World Health Organization. Advocacy in mental health. World Health Organization, Singapore 2003
   Google Scholar